Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.9700 (3.35%) ($12.4000 - $13.2700) on Fri. Sep. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.96% (three month average) | RSI | 55 | Latest Price | $12.9700(3.35%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -4.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.98% in a week (0% probabilities). VIXM(-32%) VXX(-26%) UNG(-11%) UUP(-9%) TLT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.98% (StdDev 3.96%) | Hourly BBV | 0 () | Intraday Trend | 4.6% | | | |
|
Resistance Level | $14.12 | 5 Day Moving Average | $13.58(-4.49%) | 10 Day Moving Average | $14.53(-10.74%) | 20 Day Moving Average | $14.12(-8.14%) | To recent high | -18.3% | To recent low | 8.8% | Market Cap | $964m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |